Clinical Trial

Wenzhou Gestational Diabetes Cohort

Study acronym: WGDC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 3, 2025 (before its estimated March 21, 2026 completion). Its status may not reflect the trial's current state.
Summary
The Wenzhou Gestational Diabetes Cohort (WGDC) is a prospective cohort study among women with gestational diabetes mellitus (GDM) during pregnancy and their offspring living in Wenzhou, China. The primary aim of this cohort is to characterize the continuous blood glucose response to dietary intake and physical activity among pregnant women with GDM over 2 weeks, and to facilitate the development of personalized nutritional/lifestyle recommendation among these patients. Another aim of the WGDC is to investigate the association of dietary and physical activity together with continuous glucose change during pregnancy on the adverse birth outcomes including preterm birth, macrosomia and large-for-gestational-age birth. The secondary aim is to investigate the prospective associations of diet, physical activity and continuous glucose change over 2 weeks among the patients with long-term metabolic health of the women and their offspring.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-03-29; most recent amendment 2025-03-30.
Status change: Not Yet Recruiting → Recruiting 2023-06-26
Trial Details
NCT Number NCT05794152
Lead Sponsor Westlake University
Collaborators: Wenzhou People's Hospital
Conditions Gestational Diabetes Mellitus, Intrauterine Hyperglycemia, Birth Outcome, Adverse, Nutrition, Healthy
Enrollment 300 participants
Start Date 2023-03-21
Primary Completion 2026-03-21 (estimated)
Study Completion 2033-03-21 (estimated)
Updated on ClinicalTrials.gov 2025-04-03